Nemaura Medical Inc. Announces Uplist to OTCQB

Jul 10, 2017, NMRD OTC Disclosure & News Service Nemaura Medical Inc. (OTC: NMRD), a medical technology company focused on the development and commercialization of sugarBEAT®, a wireless disposable adhesive skin-patch for adjunctive use by diabetics as a non-invasive and needle-free continuous glucose monitoring (CGM) system announced it has recently uplisted to the OTCQB Venture Market trading platform. Dr Faz Chowdhury, CEO of Nemaura Medical commented We are pleased to announce our uplist to the OTC Quote Board, which
http://bit.ly/2v5dyhR